GlassScriptPhysician profile
Garrett S Wada
NPI 1033172903
$6,756.68
in general payments reported to CMS, 2019-2025
15 companies · $504 in 2025
The $504 reported for 2025 was more than what 77% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $620 · 2020: $65.97 · 2021: $690 · 2022: $237 · 2023: $1,883 · 2024: $2,757 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,713 · Food and Beverage: $2,431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,712.82 |
| Food and Beverage | $2,431.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $3,104.20 | 2022-2025 | Infuse, Biotrue One Day, Infuse Multifocal |
| Alcon Vision LLC | $1,910.05 | 2023-2025 | Precision 1, Total30, Wavelight Refractive Suite |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $729.81 | 2019-2021 | |
| Visioneering Technologies, INC. | $211.31 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $169.58 | 2020-2023 | |
| Dompe US, INC. | $150.13 | 2024 | Oxervate |
| Lumenis, INC | $122.54 | 2021 | |
| Glaukos Corporation | $97.24 | 2021 | |
| Optovue, INC. | $89.49 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $52.23 | 2021-2023 | Acuvue |
| Sun Pharmaceutical Industries INC. | $24.99 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $24.93 | 2024 | |
| Mallinckrodt Hospital Products INC. | $24.76 | 2022 | |
| Abbvie INC. | $24.60 | 2022 | |
| Harrow Eye, LLC | $20.82 | 2025 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garrett Wada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.